Literature DB >> 19124820

Immunization policy development in the United States: the role of the Advisory Committee on Immunization Practices.

Jean C Smith1, Dixie E Snider, Larry K Pickering.   

Abstract

The Advisory Committee on Immunization Practices (ACIP) consists of 15 experts in immunization and related fields, selected by the Secretary of the U.S. Department of Health and Human Services, to provide advice and guidance on control of vaccine-preventable diseases. In its role as a federal advisory committee, the ACIP develops written recommendations, subject to approval of the Director of the Centers for Disease Control and Prevention, for administration of U.S. Food and Drug Administration-licensed vaccines to children, adolescents, and adults in the U.S. civilian population. On the basis of careful review of available scientific data, including disease morbidity and mortality in the general U.S. population and in specific risk groups, vaccine safety and efficacy, cost-effectiveness, and related factors, the ACIP recommends vaccines and age for vaccine administration, number of doses and dosing interval, and precautions and contraindications. The ACIP works closely with several liaison organizations, including the American College of Physicians, to develop immunization recommendations that are harmonized among key professional medical organizations in the United States. This report includes a description of the member composition of the ACIP, the degree to which Committee members are screened for conflicts of interest, the workgroups that gather information before full Committee consideration, and the process and types of evidence used to formulate recommendations.

Entities:  

Mesh:

Year:  2009        PMID: 19124820     DOI: 10.7326/0003-4819-150-1-200901060-00009

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  15 in total

1.  EBM, HTA, and CER: clearing the confusion.

Authors:  Bryan R Luce; Michael Drummond; Bengt Jönsson; Peter J Neumann; J Sanford Schwartz; Uwe Siebert; Sean D Sullivan
Journal:  Milbank Q       Date:  2010-06       Impact factor: 4.911

Review 2.  Evolution of cervical cancer screening and prevention in United States and Canada: implications for public health practitioners and clinicians.

Authors:  M Saraiya; M Steben; M Watson; L Markowitz
Journal:  Prev Med       Date:  2013-02-08       Impact factor: 4.018

3.  Physician Attitudes Toward Adult Vaccines and Other Preventive Practices, United States, 2012.

Authors:  Laura P Hurley; Carolyn B Bridges; Rafael Harpaz; Mandy A Allison; Sean T O' Leary; Lori A Crane; Michaela Brtnikova; Shannon Stokley; Brenda L Beaty; Andrea Jimenez-Zambrano; Allison Kempe
Journal:  Public Health Rep       Date:  2016 Mar-Apr       Impact factor: 2.792

4.  Childhood immunization policies and the prevention of communicable disease.

Authors:  James H Conway; Tiffany Green
Journal:  Pediatr Ann       Date:  2011-03       Impact factor: 1.132

5.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal:  MMWR Recomm Rep       Date:  2018-04-27

6.  Racial and ethnic disparities in influenza vaccinations among community pharmacy patients and non-community pharmacy respondents.

Authors:  Junling Wang; Kiraat D Munshi; Song Hee Hong
Journal:  Res Social Adm Pharm       Date:  2013-05-23

7.  Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention--convened meeting.

Authors:  Cheryl S Broussard; Meghan T Frey; Sonia Hernandez-Diaz; Michael F Greene; Christina D Chambers; Leyla Sahin; Beth A Collins Sharp; Margaret A Honein
Journal:  Am J Obstet Gynecol       Date:  2014-05-29       Impact factor: 8.661

8.  Vaccine-Associated Anaphylaxis.

Authors:  Michael M McNeil
Journal:  Curr Treat Options Allergy       Date:  2019-07-16

9.  Understanding FDA-Approved Labeling and CDC Recommendations for Use of Vaccines.

Authors:  H Cody Meissner; Karen Farizo; Douglas Pratt; Larry K Pickering; Amanda C Cohn
Journal:  Pediatrics       Date:  2018-09       Impact factor: 7.124

10.  Evidence and policymaking: The introduction of MMR vaccine in the Netherlands.

Authors:  Stuart Blume; Janneke Tump
Journal:  Soc Sci Med       Date:  2010-07-13       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.